ASCO Issues Guideline on Neoadjuvant Chemotherapy for Advanced Ovarian Cancer

In a new practice guideline, the American Society of Clinical Oncology offered recommendations on the use of neoadjuvant chemotherapy and interval cytoreduction for women with stage IIIC or IV epithelial ovarian cancer.
Source: CancerNetwork - Category: Cancer & Oncology Authors: Tags: Gynecologic Cancers News Ovarian Cancer Source Type: news